$8.05
-0.09-1.11%
Pre-Market: 4:06 AM EDT
15 minutes delayed
Comments
Loading...
Recursion Pharmaceuticals
RXRXNASDAQ
Recursion Pharmaceuticals (RXRX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRecursion Pharmaceuticals (NASDAQ:RXRX) Stock Quotes, Forecast and News Summary
Recursion Pharmaceuticals Stock (NASDAQ: RXRX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 250.00 / 5.61M |
| Day Range | - - - |
| 52 Wk Range | 4.97 - 16.09 |
| Market Cap | $2.16B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 50 |
| Short Interest | 23.84% |
| Days to Cover | 4.67 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Recursion Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by i...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Recursion Pharmaceuticals (RXRX) stock?
You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.
Who are Recursion Pharmaceuticals (RXRX) competitors?
Other companies in Recursion Pharmaceuticals’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), PTC Therapeutics (NASDAQ:PTCT), Protagonist Therapeutics (NASDAQ:PTGX), Novavax (NASDAQ:NVAX) and CG Oncology (NASDAQ:CGON).
What is the target price for Recursion Pharmaceuticals (RXRX) stock?
There is no analysis for Recursion Pharmaceuticals.
What is the forecast for Recursion Pharmaceuticals (RXRX) stock?
Recursion Pharmaceuticals has a consensus price target of $14.29.
Current stock price for Recursion Pharmaceuticals (RXRX)?
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $8.05 last updated Today at July 23, 2024 at 4:06 AM EDT.
Does Recursion Pharmaceuticals (RXRX) pay a dividend?
There are no upcoming dividends for Recursion Pharmaceuticals.
When is Recursion Pharmaceuticals (NASDAQ:RXRX) reporting earnings?
Recursion Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Recursion Pharmaceuticals (RXRX) going to split?
There is no upcoming split for Recursion Pharmaceuticals.
What sector and industry does Recursion Pharmaceuticals (RXRX) operate in?
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.